처방용 피부과 의약품 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global prescription dermatological drugs market size is expected to reach USD 83.03 Billion in 2034 from USD 44.07 Billion in 2025, growing at a CAGR of 7.29 during 2026-2034.This market has experienced significant growth due to the rising prevalence of skin disorders and increasing awareness regarding dermatological health. Prescription dermatological drugs are widely used for the treatment of conditions such as acne, psoriasis, eczema, dermatitis, fungal infections, and skin cancers. Growing healthcare access and improved diagnostic capabilities have enabled earlier identification and treatment of skin-related diseases. The expanding focus on both medical and aesthetic dermatology has further contributed to market growth.

Key growth drivers include increasing incidences of chronic skin conditions, growing demand for advanced treatment options, and continuous pharmaceutical innovation. The development of targeted therapies, biologics, and novel topical formulations has improved treatment outcomes and patient satisfaction. Rising healthcare expenditures and greater awareness regarding skin health have encouraged more individuals to seek professional treatment. Additionally, expanding dermatology services and specialist availability continue to strengthen market demand.

Future prospects remain highly favorable as research and development activities generate innovative therapies with improved efficacy and safety profiles. Personalized medicine approaches, biologic treatments, and advanced drug delivery technologies are expected to transform dermatological care. Growing healthcare infrastructure in emerging economies and increasing consumer awareness regarding skin health will further support market expansion. As the global burden of dermatological conditions continues to rise, the prescription dermatological drugs market is expected to experience sustained long-term growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Drug Class

• Corticosteroids
• Retinoids
• Calcineurin Inhibitors
• Antifungal Agents
• Antibiotics
• Other Drug Classes

By Indication

• Acne
• Psoriasis
• Dermatitis
• Fungal Skin Infections
• Other Indications

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels

COMPANIES PROFILED

• Pfizer Inc., Johnson & Johnson, Merck KGaA, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Zydus Cadila Healthcare Limited, Regeneron Pharmaceuticals Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRESCRIPTION DERMATOLOGICAL DRUGS MARKET: BY DRUG CLASS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Class
• 4.2. Corticosteroids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Retinoids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Calcineurin Inhibitors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Antifungal Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Antibiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Other Drug Classes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRESCRIPTION DERMATOLOGICAL DRUGS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Acne Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Psoriasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Dermatitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Fungal Skin Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Indications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRESCRIPTION DERMATOLOGICAL DRUGS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Distribution Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRESCRIPTION DERMATOLOGICAL DRUGS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Drug Class
  • 7.2.2 By Indication
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Drug Class
  • 7.3.2 By Indication
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Drug Class
  • 7.4.2 By Indication
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Drug Class
  • 7.5.2 By Indication
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Drug Class
  • 7.6.2 By Indication
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PRESCRIPTION DERMATOLOGICAL DRUGS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Pfizer Inc
  • 9.2.2 Johnson & Johnson
  • 9.2.3 Merck KGaA
  • 9.2.4 AbbVie Inc
  • 9.2.5 Bayer AG
  • 9.2.6 Novartis AG
  • 9.2.7 GSK Plc
  • 9.2.8 Amgen Inc
  • 9.2.9 Teva Pharmaceutical Industries Ltd
  • 9.2.10 Mylan N.V
  • 9.2.11 Sun Pharmaceutical Industries Ltd
  • 9.2.12 Cipla Limited
  • 9.2.13 Dr. Reddy's Laboratories Ltd
  • 9.2.14 Zydus Cadila Healthcare Limited
  • 9.2.15 Regeneron Pharmaceuticals Inc